Sign In
Buy ILMN
$168.06
-2.87 (-1.68%)
At Close: Jun 04, 2026
Illumina retains ‘Buy' rating from Canaccord as activist investor Carl Icahn prepares for face-off
02:41pm, Tuesday, 14'th Mar 2023
Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have reiterated their ‘Buy' rating and $300 price target for Illumina Inc (NASDAQ:ILMN) after activist investor Carl Icahn said he is preparing a p
Carl Icahn Pens Open Letter to Illumina Shareholders
03:52pm, Monday, 13'th Mar 2023
Sunny Isles Beach, Florida, March 13, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).
Illumina: It's not in the ‘best interests' of shareholders to support Carl Icahn's nominees to the board
02:43pm, Monday, 13'th Mar 2023
Illumina Inc. ILMN said Monday it received notice from Icahn Partners that the organization plans to nominate three candidates to to the board over concerns about the company's $7.1 billion acquisitio
'Something is rotten in the state of Illumina,' says activist investor Carl Icahn as he takes aim over Grail pursuit
02:04pm, Monday, 13'th Mar 2023
Illumina Inc (NASDAQ:ILMN) stock rallied more than 20% following reports in the Wall Street Journal that activist investor Carl Icahn is preparing a proxy fight at the gene sequencing company after
ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina
09:57am, Monday, 13'th Mar 2023
Illumina (NASDAQ: ILMN ) stock is a hot topic among traders on Monday as reports claim Carl Icahn is gearing up for a proxy fight. According to a report from The Wall Street Journal, Icahn has issues
WSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billion
08:24am, Monday, 13'th Mar 2023
Shares of Illumina Inc. ILMN, -4.24% were up about 8% in premarket trading on Monday after the Wall Street Journal reported Sunday that Carl Icahn is planning a proxy fight. The billionaire activist r
Carl Icahn prepares for proxy fight at Illumina - WSJ
10:22pm, Sunday, 12'th Mar 2023
Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc , arguing that the life science maker's acquisition of Grail Inc cost its shareholders roughly $50 billion, the Wall Street Jour
Icahn Prepares for Proxy Fight at Illumina
09:13pm, Sunday, 12'th Mar 2023
The billionaire activist seeks three seats on biotech's board.
Steer Clear Of These 4 Toxic Stocks to Avoid Losses
08:28am, Friday, 10'th Mar 2023
Correctly spotting overpriced stocks and shunning them at the right time may avoid portfolio bleeding. ILMN, LTRX, BSY and CDMO are a few such toxic stocks.
Final Trades: Illumina, JPMorgan & more
02:58pm, Thursday, 09'th Mar 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Illumina To Webcast Upcoming Investor Conference
04:10pm, Monday, 27'th Feb 2023
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 43rd Annual Cowen Health Care Confere
7 Stocks to Buy and Hold for the Next 20 Years
07:42am, Sunday, 12'th Feb 2023
When looking for stocks to buy and hold for the next 20 years, it's essential to find ones with economic moat. After all, when it comes to picking stocks, they should strong competitive advantages tha
Illumina (ILMN) Q4 Earnings Miss Estimates, Gross Margin Down
12:03pm, Wednesday, 08'th Feb 2023
Delays in recruitment for some large research projects in the Americas and Europe, the impact of COVID disruptions in China and foreign exchange woes hurt Illumina's (ILMN) Q4 revenues.
Illumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
04:31am, Wednesday, 08'th Feb 2023
While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compa
Illumina, Inc. (ILMN) Q4 2022 Earnings Call Transcript
09:13pm, Tuesday, 07'th Feb 2023
Illumina, Inc. (NASDAQ:ILMN ) Q4 2022 Earnings Conference Call February 7, 2023 5:00 PM ET Company Participants Sallilyn Schwartz - VP, IR Joydeep Goswami - CFO, Chief Strategy & Corporate Development
